Global Plan to End TB: 2016-2020 Insights and Impacts
Explore the comprehensive Global Plan to End Tuberculosis (TB) for the years 2016-2020, highlighting key strategies, initiatives, and the cost of inaction. Uncover the urgency and critical need for continued investment in new tools to combat TB effectively. Join the conversation and learn more about the innovative approaches at www.newtbdrugs.org.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
The Global Plan To End TB 2016-2020 Cherise Scott, Secretariat 2015 Annual Meeting Cape Town, South Africa www.newtbdrugs.org
The Global Plan 2016-2020 Special committee: Mel Spigelman Barbara Laughon Cherise Scott Myriam Haxaire-Theeuwes (Janssen) Peter Warner (Gates) Christian Lienhardt (WHO) Consultation with Community Representatives Online consultation broader community
The New Drugs Framework for 2016-2020
Cost of Inaction By 2030, a five-year delay in investment for new tools is estimated to result in: 3) 39.8 MILLION DALYS SUFFERED 1)8.4 MILLION ADDITIONAL TB CASES 2) 1.4 MILLION ADDITIONAL TB DEATHS (56.1 million without discounting) 4) US$ 5.3 BILLION IN ADDITIONAL COSTS FOR TB TREATMENTS 5) US$ 181 BILLION IN LOST PRODUCTIVITY (US$ 318 billion without discounting), valuing each DALY at per-capita GNI. (US$ 7.5 billion without discounting) Source: Stop TB Partnership s Global Plan 2016-2020 Introduction of Child-Friendly TB Medicines 6
THANK YOU Explore. Learn. Join the conversation. www.newtbdrugs.org
